Ausgabe 4/2024
Inhalt (6 Artikel)
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials
- Leading Article
Gareth Baynam, Simeón Baker, Charles Steward, Marshall Summar, Meghan Halley, Anne Pariser
How Can General Managers Best Leverage Medical Affairs Now and in the Future?
- Open Access
- Current Opinion
Jon Zdon, Greta-James Chatgilaou, David Henderson, Matthew Britland, Sarah Tregenza, Nathalie McNeil, Dirk Otto, Josie Downey
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
- Open Access
- Review Article
Malia A. Belnap, Kaitlin R. McManus, Erica N. Grodin, Lara A. Ray
Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA
- Original Research Article
Victor L. Van de Wiele, Aaron S. Kesselheim, Deborah Gleeson, Zhigang Lu, Sean S. Tu, Benjamin N. Rome
Considerations for Planning Effective and Appealing Advisory Boards and Other Small-Group Meetings with Health Care Providers: Importance of Participant Preferences
- Open Access
- Original Research Article
Cecilia Petrus, Holly Lam
Statistical Signal Detection Algorithm in Safety Data: A Proprietary Method Compared to Industry Standard Methods
- Original Research Article
Eugenia Bastos, Jeff K. Allen, Jeff Philip
